AP4 (Iclusig 45 mg)
Generic Name: ponatinib
Pill imprint AP4 has been identified as Iclusig 45 mg.
Iclusig is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iclusig 45 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for AP4 (Iclusig 45 mg)
Iclusig
- Generic Name:
- ponatinib
- Imprint:
-
AP4
- Strength:
- 45 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- ARIAD Pharmaceuticals, Inc.
More resources
Iclusig is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
